Antares Pharma: 4Q Earnings Snapshot

March 3, 2020 GMT

EWING, N.J. (AP) _ Antares Pharma Inc. (ATRS) on Tuesday reported fourth-quarter profit of $4.7 million.

The Ewing, New Jersey-based company said it had profit of 3 cents per share.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was breakeven on a per-share basis.

The drugmaker posted revenue of $37.8 million in the period.

For the year, the company reported that its loss narrowed to $2 million, or 1 cent per share. Revenue was reported as $123.9 million.

Antares Pharma expects full-year revenue in the range of $135 million to $155 million.

The company’s shares closed at $3.22. A year ago, they were trading at $3.72.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRS at https://www.zacks.com/ap/ATRS